Literature DB >> 12425460

Improved inhalation behavior of steroid KSR-592 in vitro with Jethaler by polymorphic transformation to needle-like crystals (beta-form).

Kazuhiko Ikegami1, Yoshiaki Kawashima, Hirofumi Takeuchi, Hiromitsu Yamamoto, Nobuyuki Isshiki, Den-Ichi Momose, Kiyohisa Ouchi.   

Abstract

PURPOSE: The aim of the present study was to improve the dry powder inhalation behavior of steroid KSR-592 with lactose by altering the crystal shape and the particle size of the drug for use in a newly designed inhalation device, Jethaler.
METHOD: The shape of the crystals was changed by polymorphic transformation of original crystal (alpha-form) to beta-form by agitating alpha-form crystals in hexane containing 5% ethanol. The inhalation properties of the resultant crystals in vitro were evaluated with a twin impinger and cascade impactor.
RESULTS: Needle-like crystals (beta-form) with dimensions of 1.8 microm in width x 41 microm in length were obtained by the polymorphic transformation, the kinetics of which was described by the Avrami equation. The beta-form crystals loaded on lactose particles were easily separated and crushed into fine particles in the airstream produced in the Jethaler, which increased dramatically the respirable fraction (RF) deposited in the twin impinger (43.8%) and the fine particle fraction (FPF) of the cascade impactor (FPF = 39.3%) compared with their values for the original crystals (RF = 5.8%, FPF = 4.7%).
CONCLUSION: The dry powder inhalation properties of steroid KSR-592 (platelike crystal, alpha-form) were improved dramatically by changing the crystal shape to a needle-like shape by the polymorphic transformation to the beta-form.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425460     DOI: 10.1023/a:1020492213172

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

1.  An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified 'Kirk Lung'.

Authors:  P J Davies; G W Hanlon; A J Molyneux
Journal:  J Pharm Pharmacol       Date:  1976-12       Impact factor: 3.765

2.  Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols.

Authors:  K A Fults; I F Miller; A J Hickey
Journal:  Pharm Dev Technol       Date:  1997-02       Impact factor: 3.133

3.  Measurements of the adhesive force between particles of powdered organic substances and a glass substrate by means of the impact separation method. II. Effect of addition of light anhydrous silicic acid on the adhesive force of potato starch.

Authors:  A Otsuka; K Iida; K Danjo; H Sunada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-09       Impact factor: 1.645

Review 4.  Inhaled glucocorticoids for asthma.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

  4 in total
  8 in total

1.  How much particle surface corrugation is sufficient to improve aerosol performance of powders?

Authors:  Nora Y K Chew; Patricia Tang; Hak-Kim Chan; Judy A Raper
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

Review 2.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

3.  Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity.

Authors:  Satomi Onoue; Kazuki Kuriyama; Atsushi Uchida; Takahiro Mizumoto; Shizuo Yamada
Journal:  Pharm Res       Date:  2011-02-02       Impact factor: 4.200

4.  Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.

Authors:  Eleonora Maretti; Luca Costantino; Francesca Buttini; Cecilia Rustichelli; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

5.  Ultrasound assisted engineering of lactose crystals.

Authors:  Ravindra S Dhumal; Shailesh V Biradar; Anant R Paradkar; Peter York
Journal:  Pharm Res       Date:  2008-07-01       Impact factor: 4.200

6.  Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics.

Authors:  Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Pharm Res       Date:  2022-09-07       Impact factor: 4.580

7.  In Silico Optimization of Fiber-Shaped Aerosols in Inhalation Therapy for Augmented Targeting and Deposition across the Respiratory Tract.

Authors:  Lihi Shachar-Berman; Saurabh Bhardwaj; Yan Ostrovski; Prashant Das; Pantelis Koullapis; Stavros Kassinos; Josué Sznitman
Journal:  Pharmaceutics       Date:  2020-03-05       Impact factor: 6.525

8.  The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant.

Authors:  Eleonora Maretti; Cecilia Rustichelli; Magdalena Lassinantti Gualtieri; Luca Costantino; Cristina Siligardi; Paola Miselli; Francesca Buttini; Monica Montecchi; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Pharmaceutics       Date:  2019-10-01       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.